Review article: Pharmacologic management of obesity - updates on approved medications, indications and risks.
Camille Lupianez-MerlySaam DilmaghaniKia VosoughiMichael CamilleriPublished in: Alimentary pharmacology & therapeutics (2024)
AOMs have established efficacy and effectiveness for weight loss even beyond 52 weeks. Further pharmacological options, such as dual and triple incretins, are probable forthcoming additions to clinical practice for combating obesity and its metabolic consequences such as metabolic dysfunction-associated steatotic liver disease.
Keyphrases
- weight loss
- bariatric surgery
- clinical practice
- roux en y gastric bypass
- insulin resistance
- metabolic syndrome
- gastric bypass
- weight gain
- high fat diet induced
- type diabetes
- randomized controlled trial
- systematic review
- glycemic control
- adipose tissue
- human health
- obese patients
- risk assessment
- skeletal muscle
- gestational age